<DOC>
	<DOCNO>NCT00392678</DOCNO>
	<brief_summary>Growing evidence recent year support potential role low grade chronic inflammation pathogenesis insulin resistance type 2 diabetes . In study determine whether salsalate , member commonly use Non-Steroidal Anti-Inflammatory Drug ( NSAID ) class , effective lowering sugar patient type 2 diabetes . The study determine whether salicylate represent new pharmacological option diabetes management . The study conduct two stage . The first stage dose range study , administer salsalate compare placebo three month . The primary objective Stage 2 study evaluate effect salsalate blood sugar control diabetes ; tolerability salsalate use patient type 2 diabetes ( T2D ) ; effect salsalate measure inflammation , metabolic syndrome , cardiac risk . The second stage second trial post alternate registration .</brief_summary>
	<brief_title>Targeting INflammation Using SALsalate Type 2 Diabetes ( TINSAL-T2D )</brief_title>
	<detailed_description>The primary objective first stage TINSAL-T2D trial select dose salsalate well-tolerated demonstrates trend toward improvement glycemic control . The trial multicenter , single mask lead-in , double mask placebo control dose range study , compare salsalte placebo 3 month .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Salicylsalicylic acid</mesh_term>
	<mesh_term>Sodium Salicylate</mesh_term>
	<criteria>1 . Type 2 diabetes diet exercise therapy monotherapy metformin , insulin secretagogue , alphaglucosidase inhibitor , lowdose combination ≤ 50 % maximal dose ( see Appendix ) . Dosing stable 8 week prior randomization . 2 . FPG ≤ 225 mg/dL HbA1c &gt; 7 % ≤9.5 % screen 3 . Age ≥18 &lt; 75 4 . Women childbearing potential agree use appropriate contraceptive method ( hormonal , IUD , diaphragm ) 1 . Type 1 diabetes and/or history ketoacidosis determine medical history 2 . History severe diabetic neuropathy include autonomic neuropathy , gastroparesis lower limb ulceration amputation 3 . History longterm therapy insulin ( &gt; 30 day ) within last year 4 . Therapy rosiglitazone ( Avandia ) pioglitazone ( Actos ) , extendin4 ( Byetta ) , alone combination previous 6 month 5 . Pregnancy lactation 6 . Patients require corticosteroid within 3 month recurrent continuous oral corticosteroid treatment ( 2 week ) 7 . Use weight loss drug [ e.g. , Xenical ( orlistat ) , Meridia ( sibutramine ) , Acutrim ( phenylpropanolamine ) , similar overthecounter medication ] within 3 month screen intentional weight loss ≥ 10 lb previous 6 month 8 . Surgery within 30 day prior screen 9 . Serum creatinine &gt; 1.4 woman &gt; 1.5 men eGFR &lt; 60 [ possible chronic kidney disease stage 3 great calculate use Modification Diet Renal Disease ( MDRD ) equation . 10 . History chronic liver disease include hepatitis B C 11 . History peptic ulcer endoscopy demonstrate gastritis 12 . History acquire immune deficiency syndrome human immunodeficiency virus ( HIV ) 13 . History malignancy , except participant diseasefree great 10 year , whose malignancy basal squamous cell skin carcinoma 14 . New York Heart Association Class III IV cardiac status hospitalization congestive heart failure 15 . History unstable angina , myocardial infarction , cerebrovascular accident , transient ischemic attack revascularization within 6 month 16 . Uncontrolled hypertension ( define systolic blood pressure &gt; 150 mmHg diastolic blood pressure &gt; 95 mmHg three assessment one day ) 17 . History drug alcohol abuse , current weekly alcohol consumption &gt; 10 units/week ( 1 unit = 1 beer , 1 glass wine , 1 mixed cocktail contain 1 ounce alcohol ) 18 . Hemoglobin &lt; 12 g/dL ( male ) , &lt; 10 g/dL ( female ) screen 19 . Platelets &lt; 100,000 cu mm screening . 20 . AST ( SGOT ) &gt; 2.50 x ULN ALT ( SGPT ) &gt; 2.50 x ULN screen 21 . Total Bilirubin &gt; 1.50 x ULN screen 22 . Triglycerides ( TG ) &gt; 500 mg/dL screen 23 . Poor mental function reason expect patient difficulty comply requirement study 24 . Previous allergy aspirin 25 . Chronic continuous use ( daily 7 day ) nonsteroidal antiinflammatory drug within precede 2 month 26 . Use warfarin ( Coumadin ) , clopidogrel ( Plavix ) anticoagulants 27 . Use probenecid ( Benemid , Probalan ) , sulfinpyrazone ( Anturane ) uricosuric agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Obesity</keyword>
	<keyword>Metabolic Syndrome</keyword>
</DOC>